Portal de Periódicos da CAPES

Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art

2016; Baishideng Publishing Group; Volume: 8; Issue: 10 Linguagem: Inglês

10.4329/wjr.v8.i10.829

1949-8470

Federico Caobelli, Laura Evangelista, Natale Quartuccio, Demetrio Familiari, Corinna Altini, Angelo Castello, Mariapaola Cucinotta, Rossella Di Dato, Cristina Ferrari, Aurora Kokomani, Iashar Laghai, Riccardo Laudicella, Silvia Migliari, Federica Orsini, Salvatore Antonio Pignata, Cristina Raluca Gh. Popescu, Erinda Puta, Martina Ricci, Silvia Seghezzi, Alessandro Sindoni, Martina Sollini, Letterio Sturiale, Anna Svyridenka, Vittoria Vergura, Pierpaolo Alongi, Young Aimn Working Group,

Microscopic Colitis

AIMTo present the current state-of-the art of molecular imaging in the management of patients affected by inflammatory bowel disease (IBD). METHODSA systematic review of the literature was performed in order to find important original articles on the role of molecular imaging in the management of patients affected by IBD.The search was updated until February 2016 and limited to articles in English. RESULTSFifty-five original articles were included in this review, highlighting the role of single photon emission tomography and positron emission tomography. CONCLUSIONTo date, molecular imaging represents a useful tool to detect active disease in IBD.However, the available data need to be validated in prospective multicenter studies on larger patient samples.